scholarly article | Q13442814 |
P50 | author | Stephen D Marks | Q88575714 |
Neil J. Sebire | Q38549176 | ||
George Michaelides | Q59393707 | ||
P2093 | author name string | Robert Vaughan | |
Nizam Mamode | |||
Anthony Dorling | |||
Chloe Martin | |||
Olivia Shaw | |||
Jon Jin Kim | |||
Ramnath Balasubramaniam | |||
P2860 | cites work | The perfect storm: HLA antibodies, complement, FcγRs, and endothelium in transplant rejection | Q26862195 |
Long-term outcomes of children after solid organ transplantation | Q28660815 | ||
Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss. | Q35027253 | ||
HLA sensitisation: can it be prevented? | Q35097898 | ||
Capillary deposition of complement C4d and C3d in Chinese renal allograft biopsies | Q35189649 | ||
Cellular response to injury in membranous nephropathy | Q36084457 | ||
Antibody-Mediated Rejection Due to Preexisting versus De Novo Donor-Specific Antibodies in Kidney Allograft Recipients. | Q36296061 | ||
IgG Donor-Specific Anti-Human HLA Antibody Subclasses and Kidney Allograft Antibody-Mediated Injury | Q36417907 | ||
Calcineurin-inhibitor free immunosuppression with mycophenolate mofetil and corticosteroids in paediatric renal transplantation improves renal allograft function without increasing acute rejection | Q37320783 | ||
Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA. | Q37667779 | ||
Complement as a multifaceted modulator of kidney transplant injury | Q38217273 | ||
Kidney transplantation in children | Q38237543 | ||
Association of C1q-fixing DSA with late graft failure in pediatric renal transplant recipients | Q87395286 | ||
Determinants of C1q binding in the single antigen bead assay | Q88058283 | ||
Complement activation in progressive renal disease | Q38348940 | ||
Assessing Antibody Strength: Comparison of MFI, C1q, and Titer Information. | Q40990548 | ||
Mycophenolate mofetil substitution for cyclosporine a in renal transplant recipients with chronic progressive allograft dysfunction: the "creeping creatinine" study | Q45281312 | ||
Systematic comparison of four cell- and Luminex-based methods for assessment of complement-activating HLA antibodies | Q45332005 | ||
Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation | Q45627897 | ||
Complement-binding anti-HLA antibodies and kidney-allograft survival | Q46141053 | ||
Early versus late acute antibody-mediated rejection in renal transplant recipients. | Q46415040 | ||
Early and late acute antibody-mediated rejection differ immunologically and in response to proteasome inhibition. | Q53244973 | ||
The Clinical Spectrum ofDe NovoDonor-Specific Antibodies in Pediatric Renal Transplant Recipients | Q57521747 | ||
Acquisition of C3d-Binding Activity by De Novo Donor-Specific HLA Antibodies Correlates With Graft Loss in Nonsensitized Pediatric Kidney Recipients | Q87006000 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 1 | |
P304 | page(s) | 167-174 | |
P577 | publication date | 2017-09-16 | |
P1433 | published in | Pediatric Nephrology | Q15749796 |
P1476 | title | Clinical risk stratification of paediatric renal transplant recipients using C1q and C3d fixing of de novo donor-specific antibodies | |
P478 | volume | 33 |
Q89529172 | C3d-Positive Preformed DSAs Tend to Persist and Result in a Higher Risk of AMR after Kidney Transplants |
Q59807564 | Clinical impact of complement (C1q, C3d) binding De Novo donor-specific HLA antibody in kidney transplant recipients |
Q63866084 | Pretransplant C3d-Fixing Donor-Specific Anti-HLA Antibodies Are Not Associated with Increased Risk for Kidney Graft Failure |
Q92525914 | Prognostic value of C3d-fixing, preformed donor-specific antibodies in crossmatch-positive living kidney transplantation |
Search more.